RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Novo Holdings
N

Novo Holdings portfolio

Novo Holdings has 22 portfolio companies on record at Recent Funding, with 6 investments in the last 12 months.

Type: Family office.
Portfolio on Recent Funding: 22.
Deals, last 12 months: 6.
Rounds led: 13 of 28.
Capital in their rounds: $2.3B.
Latest deal: Commit Biologics · Nov 17, 2026.
About this page

It is a family office based in Hellerup, DK, founded in 1999. It led 13 of the 28 rounds it joined. Its most recent investment on record is Commit Biologics's $60M Seed round in November 2026, alongside AbbVie, Ackermans & van Haaren, Ackermans & and 3 others. By category, its portfolio leans toward Health and bio (20) and Manufacturing and industrial (2). It has co-invested with Sound Bioventures, Sofinnova Partners and Catalio, most often Sound Bioventures (4 rounds).

About Novo Holdings

Firm type: Family office.
Headquarters: Hellerup, DK.
Founded: 1999.
Stages: Seed, Series A, Series B, Series C, Growth, Late Stage.
Sectors: AgTech, Biotech, Cleantech, Climate Tech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices, New Materials.
Check size: $1.08M to $54M.
Leads rounds: Yes.
Portfolio companies: 33.
Exits: 1.
Rounds led: 23.

What Novo Holdings invests in

Novo Holdings recent investments

How Novo Holdings invests

StageDealsCapital in rounds
Series A 12 43%$952.47M
Series B+ 11 39%$1.24B
Seed 5 18%$109.31M
YearDealsCapital in rounds
2018 1 4%undisclosed
2021 1 4%$68M
2022 4 14%$271.12M
2023 2 7%$112.83M
2024 6 21%$426.19M
2025 8 29%$751.99M
2026 6 21%$670.51M

Novo Holdings portfolio companies

CompanyRound with Novo HoldingsTotal raisedLatest raise
CCommit Biologics
Health and bio
Seed · $60M$77.19MNov 17, 2026
Seed
OOMass Therapeutics
Health and bio
Series B+ · $310M · lead$422.51MOct 15, 2026
Series B+
AAnaCardio
Health and bio
Series B+ · $70.97M · lead$89.97MSep 30, 2026
Series B+
BBreye Therapeutics
Health and bio
Series A · $76.65M · lead$80.77MSep 29, 2026
Series A
CClaris Bio
Health and bio
Series B+ · $118M$175MJul 28, 2026
Series B+
BBactolife
Health and bio
Series B+ · $34.9M$76.16MJan 6, 2026
Series B+
SSidera Bio
Health and bio
Series A · $109.99M$109.99MNov 4, 2025
Series A
GGlycoEra
Health and bio
Series B+ · $130M · lead$179MMay 27, 2025
Series B+
GGlycomine
Health and bio
Series B+ · $115M$195MMay 9, 2025
Series B+
AAugustine Therapeutics
Health and bio
Series A · $85M · lead$103.17MMar 24, 2025
Series A
WWindward Bio
Health and bio
Series A · $200M · lead$200MMay 5, 2026
round
OOrbis Medicines
Health and bio
Series A · $93M$121MJan 6, 2025
Series A
KKivu Bioscience
Health and bio
Series A · $92M · lead$92MOct 28, 2024
Series A
AAvenCell
Health and bio
Series B+ · $112M · lead$112MOct 22, 2024
Series B+
MMyricx Bio
Health and bio
Series A · $120M · lead$120MJul 8, 2024
Series A
NNMD Pharma
Health and bio
Series B+ · $80M$80MNov 15, 2023
Series B+
IInspirna
Health and bio
Series B+ · $50M$50MJul 11, 2022
Series B+
RRondo Therapeutics
Health and bio
Series A · $67M$67MMar 2, 2022
Series A
VVerana Health
Health and bio
Series B+ · $150M · lead$202MApr 30, 2026
Series B+
AAgnext Taranjeet Bhamra
Data and analytics
backerundisclosed—
TTribune Therapeutics AB
Health and bio
backerundisclosedMar 27, 2025
Series A
PPhasecraft
Real estate and construction
backer$34MOct 2, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 28 rounds on Recent Funding that name Novo Holdings. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Novo Holdings, which is a subset of its real portfolio. API: /api/v1/investors/novo-holdings (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy